The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Differences in survival for metastatic colorectal cancer patients by lines of therapy received.
Brian S. Seal
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
Benjamin Chastek
Employment or Leadership Position - OptumInsight
Mahesh Kulakodlu
Employment or Leadership Position - OptumInsight
Satish Valluri
Employment or Leadership Position - Bayer